Combined treatment of a juxtapapillary retinal capillary haemangioma with intravitreal bevacizumab and photodynamic therapy [9]

Eye

Volumn 21, Issue 8, 2007, Pages 1125-1126

  Ziemssen, F ^a   Voelker, M ^a   Inhoffen, W ^a   Bartz Schmidt, K U ^a   Gelisken, F ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; BEVACIZUMAB;

ADULT; CANCER STAGING; CAPILLARY HEMANGIOMA; CASE REPORT; CENTRAL SCOTOMA; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; LETTER; OPHTHALMOSCOPY; OPTIC NERVE; OUTCOME ASSESSMENT; PERIMETRY; PHOTODYNAMIC THERAPY; RETINA MACULA LUTEA; RETINA TELANGIECTASIA; TUMOR LOCALIZATION; TUMOR REGRESSION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 34547953013     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6702896     Document Type: Letter

References (5)

1. Webster AR, Maher ER, Moore AT. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 1999; 117: 371-378.
2. Schmidt-Erfurth UM, Kusserwo C, Barbazetto IA, Laqua H. Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 2002; 109: 1256-1266.
3. McCabe CM, Flynn HW, Shields CL, Shields JA, Regillo CD, McDonald HR et al. Juxtapapillary capillary hemangiomas: Clinical features and visual acuity outcomes. Ophthalmology 2000; 107: 2240-2248.
4. Wang W, Dentler WL, Borchardt RT. VEGF increases BMEC monolayer permeability by affecting occludin expression and tight Junction assembly. Am J Physiol Heart Circ Physiol 2001; 280: H434-H440.
5. Bakri SJ, Sears JE, Singh AD. Transient closure of retinal capillary hemangioma with verteporfin photodynamic therapy. Retina 2005; 25: 1103-1104.